PER 0.00% 10.5¢ percheron therapeutics limited

For General Information, page-2880

  1. 4,696 Posts.
    lightbulb Created with Sketch. 1091
    M&A rule of thumb used to be 5 x peak revenue.

    I think there was some modelling from ANP or one of the broker reports - but even if we take USA market with a 20 year product life....

    If Phase 2B is successful - I can't imagine why the Board would consider any sale for under $5 billion.

    My take on it.

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.